Protectionism and the new research imperative in pediatric AIDS.
D000163:Acquired Immunodeficiency Syndrome; D002648:Child; D003657:Decision Making; D064420:Drug-Related Side Effects and Adverse Reactions; D015507:Drugs, Investigational; D004989:Ethics; D035082:Federal Government; D006076:Government; D033161:Government Regulation; D006679:HIV Seropositivity; D006805:Human Experimentation; D006801:Humans; D028681:Moral Obligations; D033281:Nontherapeutic Human Experimentation; D033282:Parental Consent; D010344:Patient Advocacy; D004364:Pharmaceutical Preparations; D011640:Public Policy; D011788:Quality of Life; D012106:Research; D012108:Research Personnel; D035842:Research Subjects; D012306:Risk; D018570:Risk Assessment; D012926:Social Control, Formal; D012935:Social Justice; D012941:Social Responsibility; D012959:Socioeconomic Factors; D013315:Stress, Psychological; D036302:Therapeutic Human Experimentation; D020458:Third-Party Consent; D014481:United States; D035862:Vulnerable Populations; D015215:Zidovudine
Analytical Approach; Biomedical and Behavioral Research; Health Care and Public Health